-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q1 2024.
- Entero Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$66.6K, a 710% decline year-over-year.
- Entero Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$82.6K, a 95.2% increase year-over-year.
- Entero Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$24.2K, a 98.8% increase from 2022.
- Entero Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.95M, a 476% decline from 2021.
- Entero Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $519K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)